ASSOCIATION OF NON-ALCOHOLIC FATTY LIVER DISEASE WITH TYPE 2 DIABETES MELLITUS IN ADULT POPULATION

Authors

  • Saba Yousaf Farooq Hospital Westwood (FHWW)
  • Rizwan Zafar Farooq Hospital Westwood (FHWW)
  • Suneela Jabeen Farooq Hospital Westwood (FHWW)
  • Umbreen Arshad Central Park Teaching Hospital (CPTH)

DOI:

https://doi.org/10.18623/rvd.v23.5971

Keywords:

NAFLD, Type 2 Diabetes Mellitus, Fatty Liver Index, Pakistan, Metabolic Syndrome

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disorders worldwide and is strongly associated with metabolic conditions, particularly type 2 diabetes mellitus (T2DM). The coexistence of NAFLD and diabetes significantly increases the risk of liver-related morbidity and cardiovascular complications. Objective: To determine the association of NAFLD with type 2 diabetes mellitus in the adult population. Methodology: This case-control study was conducted in the Department of Medicine, Farooq Hospital / Akhtar Saeed Teaching Hospital, Lahore from October 2025 to January 2026. A total of 120 participants (60 cases with T2DM and 60 controls without diabetes) aged 30–70 years were enrolled using non-probability consecutive sampling. NAFLD was assessed using the Fatty Liver Index (FLI), calculated from triglycerides, BMI, γ-glutamyl transferase (GGT), and waist circumference. An FLI >30 was considered diagnostic of NAFLD. Data were analyzed using SPSS version 25. Odds ratio (OR) was calculated to assess the association. Results: The prevalence of NAFLD was significantly higher in diabetic patients compared to non-diabetics. The calculated odds ratio demonstrated a strong positive association (OR >1) between T2DM and NAFLD. Stratified analysis showed stronger associations in patients with higher BMI, uncontrolled HbA1c, and sedentary lifestyle. Conclusion: There is a significant association between NAFLD and type 2 diabetes mellitus. Early screening for NAFLD in diabetic patients is recommended to reduce disease progression and associated complications.

References

Abbas Z, Zaheer R. Non-alcoholic fatty liver disease: A real threat in Pakistan. Journal of the Pakistan Medical Association. 2020;70(12B):2437–40.

Ali A, Amin MJ, Ahmed MU, Taj A, Aasim M, Tabrez E. Frequency of non-alcoholic fatty liver disease (NAFLD) and its associated risk factors among Type-2 diabetics. Pakistan Journal of Medical Sciences. 2022;38(1):28.

Bud J., Cusi K. NAFLD: What does the primary care physician need to know? The American Journal of Medicine. 2020;133(5):536–43.

Castera L, Laouenan C, Vallet-Pichard A, Vidal-Trécan T, Manchon P, Paradis V, et al. High prevalence of NASH and advanced fibrosis in type 2 diabetes: a prospective study of 330 outpatients undergoing liver biopsies for elevated ALT. Diabetes Care. 2023;46(7):1354–62.

Castera L, et al. High prevalence of advanced fibrosis in patients with type 2 diabetes. Diabetes Care. 2023;46(7):1354–1362.

Cusi K, Leiva EG. Cardiovascular risk in patients with nonalcoholic fatty liver disease: looking at the liver to shield the heart. Current Opinion in Lipidology. 2020;31(6):364–6.

de Vries M, Westerink J, El-Morabit F, Kaasjager HAH, de Valk HW. Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes. Diabetes Research and Clinical Practice. 2022;186:109827.

Dharmalingam M, Yamasandhi PG. Nonalcoholic fatty liver disease and type 2 diabetes mellitus. Indian Journal of Endocrinology and Metabolism. 2018;22(3):421–8.

Eslam M, Sanyal AJ, George J. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014.

Kim K-S, Hong S, Han K, Park C-Y. Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study. BMJ. 2024;384:e076388.

Mantovani A, Byrne CD, Bonora E, Targher G. Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis. Diabetes Care. 2020;43(2):e1–e2.

Mantovani A, Petracca G, Beatrice G, Tilg H, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut. 2021;70(5):962–9.

Papadakis MA. Current Medical Diagnosis & Treatment 2024. Vietnam: McGraw Hill; 2024.

Padda J, Khalid K, Khedr A, Tasnim F, Al-Ewaidat OA, Cooper AC, et al. Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus. Cureus. 2021;13(8):e17321.

Rinella ME, et al. Nonalcoholic fatty liver disease: A systematic review. JAMA. 2023;329(3):250–265.

Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. The Lancet Diabetes & Endocrinology. 2022;10(4):284–96.

Stefan N, Häring HU, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. The Lancet Diabetes & Endocrinology. 2022;10(4):284–296.

Targher G, Byrne CD, Lonardo A, et al. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Journal of Hepatology. 2021;75(2):289–304.

Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus—mechanisms and treatments. Nature Reviews Gastroenterology & Hepatology. 2021;18(9):599–612.

Tilg H, Adolph TE, Dudek M, Knolle P. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. Nature Metabolism. 2021;3(12):1596–1606.

Tomah S, Alkhouri N, Hamdy O. Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand? Clinical Diabetes and Endocrinology. 2020;6:1–11.

Wong S-W, Chan W-K. Epidemiology of non-alcoholic fatty liver disease in Asia. Indian Journal of Gastroenterology. 2020;39(1):1–8.

Younossi ZM, et al. Global epidemiology of NAFLD and NASH. Hepatology. 2020;71(1):12–23.

Downloads

Published

2026-03-27

How to Cite

Yousaf, S., Zafar, R., Jabeen, S., & Arshad, U. (2026). ASSOCIATION OF NON-ALCOHOLIC FATTY LIVER DISEASE WITH TYPE 2 DIABETES MELLITUS IN ADULT POPULATION. Veredas Do Direito, 23(6), e235971. https://doi.org/10.18623/rvd.v23.5971

Issue

Vol. 23 No. 6 (2026): Veredas do Direito, v. 23, n. 6 2026

Section

Articles

License

I (we) submit this article which is original and unpublished, of my (our) own authorship, to the evaluation of the Veredas do Direito Journal, and agree that the related copyrights will become exclusive property of the Journal, being prohibited any partial or total copy in any other part or other printed or online communication vehicle dissociated from the Veredas do Direito Journal, without the necessary and prior authorization that should be requested in writing to Editor in Chief. I (we) also declare that there is no conflict of interest between the articles theme, the author (s) and enterprises, institutions or individuals.

I (we) recognize that the Veredas do Direito Journal is licensed under a CREATIVE COMMONS LICENSE.

 

Licença Creative Commons Attribution 3.0